Literature DB >> 3017770

Culture of human granulosa cells from an in vitro fertilization program: effects of extracellular matrix on morphology and cyclic adenosine 3',5' monophosphate production.

A Furman, S Rotmensch, J Dor, A Venter, S Mashiach, I Vlodavsky, A Amsterdam.   

Abstract

Human GCs obtained from patients undergoing an IVF procedure and treated with CC, hMG, and hCG, lack cAMP responsiveness to hCG stimulation in vitro. After 48 hours in culture, recovery of cAMP production was significantly higher in hCG-stimulated cells grown on dishes coated with ECM than in cells grown on uncoated dishes. This difference correlated with a higher degree of morphologic differentiation of cells cultured on ECM. It is concluded that ECM provides superior culture conditions for the recovery of hormone-stimulated cAMP production and the maintenance of morphologic differentiation of preovulatory GCs from stimulated cycles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017770     DOI: 10.1016/s0015-0282(16)49596-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Extracellular matrix functions in follicle maturation.

Authors:  Courtney B Berkholtz; Lonnie D Shea; Teresa K Woodruff
Journal:  Semin Reprod Med       Date:  2006-09       Impact factor: 1.303

Review 2.  The role of the extracellular matrix in ovarian follicle development.

Authors:  Teresa K Woodruff; Lonnie D Shea
Journal:  Reprod Sci       Date:  2007-12       Impact factor: 3.060

3.  Human ovarian theca cells are a source of renin.

Authors:  Y S Do; A Sherrod; R A Lobo; R J Paulson; T Shinagawa; S W Chen; S Kjos; W A Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

Review 4.  Prostaglandin E2 involvement in mammalian female fertility: ovulation, fertilization, embryo development and early implantation.

Authors:  Jean Damascene Niringiyumukiza; Hongcai Cai; Wenpei Xiang
Journal:  Reprod Biol Endocrinol       Date:  2018-05-01       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.